Achillion (ACHN), Regulus (RGLS) Price Targets Trimmed at Deutsche Bank
Tweet Send to a Friend
Deutsche Bank maintained a Buy rating on Achillion Pharmaceuticals (NASDAQ: ACHN) and lowered its price target to $20.00 (from $25.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
